HCL Tablets - Search News

Large blood pressure medication recall l Morning News Brief

FDA warns this blood pressure medication may have cancer-causing chemicals. See recall list

According to the U.S. Food and Drug Administration, 580,844 bottles of the blood pressure medication have been recalled for having high levels of chemicals that could cause cancer.

· 2h · on MSN

Common blood pressure medication recalled over high levels of cancer-causing chemical

News Nation on MSN · 10h

Blood pressure drug recalled for potential cancer-causing chemical

· 1d

Blood pressure drug recalled over cancer concerns. What it means for Ohioans

Over half a million bottles of prazosin hydrochloride capsules, a blood pressure medication, are being recalled over a cancer-causing chemical found in the prescription drug, according to the U.S. Fo...

· 7h

Nearly 600,000 bottles of blood pressure pills recalled over cancer risk

· 8h

FDA recalls blood pressure medication due to cancer-causing chemical

· 8h

FDA Recalls Blood Pressure Drug Over Cancer Risk

The FDA classified the affected batches as a Class II risk, meaning use could cause temporary or reversible health effects—and, in rare cases, more serious consequences, as reported by the AP.

· 12h

Over half-million bottles of blood pressure medication have been recalled: Here’s why

KTXS · 43m

FDA recalls blood pressure medication over cancer risk, impacting half a million bottles

Monthly Prescribing Reference

Propafenone Hcl Tablets

Propafenone HCl 150mg, 225mg; scored tabs. Propafenone, a Class 1C antiarrhythmic drug, has local anesthetic effects and a direct stabilizing action on myocardial membranes. The electrophysiological effect of propafenone manifests itself in a reduction of ...

Tonix Pharmaceuticals Presented Data on Tonmya™ (Cyclobenzaprine HCl Sublingual Tablets) at the 2025 American College of Rheumatology (ACR) Convergence

Tonmya demonstrated significant reduction in fibromyalgia pain compared with placebo in the Phase 3 RESILIENT studyTreatment was well tolerated with minimal effects on weight or blood pressure and discontinuation rate of 19% vs.